Clinical Trial Update: Gleevec Trial in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia [Phase 4]

View source ↗

Summary

ClinicalTrials.gov indicates completion of a Phase 4 trial of imatinib (Gleevec) in patients with newly diagnosed chronic phase chronic myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Gleevec (Imatinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Myelogenous Leukemia | Phase 4 | Status: COMPLETED